HIV/AIDS Viremia

HIV RNA blips during HAART may reflect ongoing viremia which impair CD4 recovery

Published in AIDS Weekly, September 19th, 2005

HIV RNA "blips" during HAART may reflect ongoing viremia that can impair CD4 T cell recovery.

"It has been demonstrated that, in patients treated by protease-inhibitor-based regimen, intermittent viremia occurred frequently and was associated with higher concentrations of residual replication but not with virological failure.

"Risk factors associated with intermittent viremia and its impact in patients treated by nonnucleoside-reverse-transcriptase-inhibitor-based (NNRTI) regimen need to be evaluated," scientists in France report.

"We analyzed the occurrence of blips (one HIV-1 RNA >50 copies/mL with a subsequent value <50...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of AIDS Weekly

Source: AIDS Weekly (2005-09-19)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry